Spyre Therapeutics, Inc. Common Stock (NASDAQ: SYRE) last traded at $85.90, up 0.25% on the session. The quote above updates while this page is open; the figures below are drawn from Spyre Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Spyre Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker SYRE. Its market capitalisation is $7.57 billion.
Valuation measures for Spyre Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.57B |
|---|---|
| Enterprise value | $7.48B |
| Price / book | 6.88 |
| Beta | 1.78 |
Trailing-twelve-month figures tagged in Spyre Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$178.92M |
|---|
| Return on equity | -16.25% |
|---|
| Cash | $162.01M |
|---|
Range and volume for SYRE over the past 52 weeks.
| 52-week high | $110.18 |
|---|---|
| 52-week low | $18.71 |
| Volume | 873.5K |
| Average volume | 1.22M |
| Previous close | $85.69 |
Invest a chosen dollar amount in Spyre Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell SYRE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.